Examkin

Question

Difficulty: HardPharmacologic Interventions

Evaluation is underway for a patient hospitalized on the medical ward who is recovering from an exacerbation of chronic obstructive pulmonary disease. The patient, who has a past medical history of heart failure with preserved ejection fraction, paroxysmal atrial fibrillation, and major depressive disorder, was initially treated with intravenous methylprednisolone and continuous nebulized albuterol. His symptoms have significantly improved, and he is now breathing comfortably on room air.

His home medications, which were continued during the admission, include diltiazem, apixaban, escitalopram, and atorvastatin. Morning laboratory results are notable for a serum potassium level of 3.1 mEq/L3.1 \text{ mEq/L} and a serum magnesium level of 1.6 mg/dL1.6 \text{ mg/dL}. A routine 12-lead electrocardiogram performed today shows normal sinus rhythm with a QTc interval of 530 milliseconds530 \text{ milliseconds}. Before the planned discharge, a sputum polymerase chain reaction panel returns positive for Mycoplasma pneumoniae, prompting the decision to initiate targeted oral antibiotic therapy.

Which of the following is the most appropriate antimicrobial regimen to prescribe for this patient?

  1. Oral doxycyclineAnswer
  2. B
    Oral azithromycin
  3. C
    Oral clarithromycin
  4. D
    Oral amoxicillin-clavulanate
  5. E
    Oral levofloxacin

Answer

The correct answer is oral doxycycline.
The correct answer is oral doxycycline. This patient requires targeted antibiotic therapy for an atypical pneumonia caused by Mycoplasma pneumoniae. The standard treatment options for atypical respiratory pathogens include macrolides, fluoroquinolones, and tetracyclines. However, this patient has multiple major risk factors for drug-induced Torsades de Pointes: a critically prolonged baseline QTc interval of 530 milliseconds530 \text{ milliseconds}, uncorrected hypokalemia and hypomagnesemia, and concurrent therapy with escitalopram, which is also known to prolong the QT interval. Doxycycline provides excellent antimicrobial coverage for Mycoplasma species and does not prolong the QT interval. Furthermore, doxycycline does not exhibit dangerous pharmacokinetic interactions with the patient's other high-risk medications, such as apixaban and diltiazem, making it the safest and most effective pharmacologic choice.

Step-by-Step Solution

1
Identify the primary diagnosis and the targeted organism.
The patient has a confirmed Mycoplasma pneumoniae infection superimposed on a chronic obstructive pulmonary disease exacerbation.
The positive sputum polymerase chain reaction indicates an atypical bacterial infection requiring specific antimicrobial coverage.
2
Determine the standard treatment options for the identified pathogen.
Mycoplasma pneumoniae is typically treated with macrolides (e.g., azithromycin, clarithromycin), fluoroquinolones (e.g., levofloxacin, moxifloxacin), or tetracyclines (e.g., doxycycline).
These classes of antibiotics are active against cell-wall deficient atypical organisms.
3
Analyze the patient's baseline risk factors and current medication list.
The patient has a severely prolonged QTc interval (530 ms530 \text{ ms}), uncorrected hypokalemia (3.1 mEq/L3.1 \text{ mEq/L}), hypomagnesemia (1.6 mg/dL1.6 \text{ mg/dL}), and is taking escitalopram.
Identifying contraindications is crucial before prescribing new medications to avoid life-threatening adverse drug events.
4
Evaluate the safety profile of the potential antibiotics.
Macrolides and fluoroquinolones are absolutely contraindicated due to their potential to further prolong the QT interval and trigger Torsades de Pointes.
Doxycycline is the only appropriate agent from the list that does not carry the risk of QT prolongation.

Key Concept

Doxycycline is the preferred antibiotic for treating atypical pneumonia in patients with a prolonged QTc interval or taking QT-prolonging medications, as it lacks the arrhythmogenic risks associated with macrolides and fluoroquinolones.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic